Dr. Brian J. Moran, Awareness in Action and Sky High Referral Rates

by | Jul 31, 2018

Dr. Brian J. Moran is the Medical Director for the Chicago Prostate Cancer Center. The Chicago Prostate Cancer Center is a specialty center that practices low-dose rate brachytherapy and has performed over 20,000 low-dose rate prostate implants since they were founded in 1997.

“Today, over 85% of our [low-dose rate brachytherapy] patients are referred from former, satisfied patients,” says Moran. Because of this, Dr. Moran recognizes the value of brachytherapy in the community and the awareness in action. Former patients have even a monthly support group meeting that Dr. Moran and his Director of Research and Education attend.

Dr. Moran credits the baby boomer generation with this awareness in action. Whether it’s through social media or simply talking to a friend, patients are being introduced to brachytherapy through channels that weren’t available 10 years ago. Dr. Moran hopes to use these new channels to share patients’ stories and testimonials.

The more widely those stories are shared, the greater the opportunity for more men to take an active role in their treatment and reaching optimal quality of life thereafter.

That said, Dr. Moran notes that the internet is not always a reliable source and that he hopes to always provide patients with the most accurate and valuable information when making their treatment decision.



If you would like to learn more about how brachytherapy improves outcomes for many types of cancer patients, especially prostate cancer patients, contact info@isoray.com.

Isoray Announces Second Quarter Fiscal 2019 Financial Results

Record Revenue and Gross Profit Revenue Increased 24% Year-Over-Year   RICHLAND, WASHINGTON - February 12, 2019 -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...

Blu Build Featured on WCIV-TV in Charleston, SC

WCIV-TV reports on the world’s first use of the Blu Build Cesium-131 brachytherapy delivery system at Hollings Cancer Center. Here’s the story on this important medical advance for prostate cancer patients and the...